Primary Endpoint Results of the EVOLVE Trial: A Randomized Evaluation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent

Study Questions:

What is the safety and efficacy of two dose formulations of SYNERGY, a novel bioabsorbable polymer everolimus-eluting stent (EES), compared with the durable polymer PROMUS Element EES?